New List Out On Medicare Part B Drugs Eligible for Rebates
Some Medicare beneficiaries may pay lower coinsurance rates from April 1 to June 30 for the drugs, HHS says.
![American pharmacist serving senior man in pharmacy](jpg/dnmljtcdd7wrvgj3em3seg-415-80.jpg)
![Joey Solitro](png/clg6elv5hiwxvnm8dtmboc.png)
The Department of Health and Human Services (HHS) has released a new list of Medicare Part B drugs that will have lower coinsurance rates from April 1 to June 30 if drugmakers raise their prices faster than the rate of inflation.
Under the Medicare Prescription Drug Inflation Rebate Program, some beneficiaries that use one or more of the 41 rebatable drugs on the list may save between $1 and $3,575 per average dose depending on their coverage, the HHS said. The agency estimates that 763,700 people with Medicare use one or more of the 41 drugs annually.
Last December, the agency released its first-quarter 2024 list of rebatable drugs under the program. There were 48 drugs in that list and Medicare coinsurance for certain Part B drugs on the list were expected to save some beneficiaries up to $2,786 per dose, HHS said at the time.
![https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png](png/hwgj7osrmtuwhk5koevme7-320-81.png)
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Drug companies are required to pay the rebates for certain drugs to Medicare when prices increase faster than inflation as part of the Biden administration’s Inflation Reduction Act, which established the program.
HHS Secretary Xavier Becerra said in a statement that the administration “will continue to use every lever we have to lower healthcare costs for more Americans.”
Drug price talks continue
In addition, drugmakers participating in Medicare's price talks on the first 10 Part D drugs sent counteroffers to the agency earlier this month, following Medicare's initial offer in February.
The drugs, covered under Part D, are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp/NovoLog.
Negotiations are slated to end August 1. New negotiated prices for the drugs expected to be announced by September 1, with an effective date of January 2026.
Guidance on Medicare programs
The Centers for Medicare & Medicaid Services (CMS) provides a variety of guidance documents on the rebatable drugs, price negotiations with drugmakers, and other Medicare programs. For more information on reducing coinsurance for certain Part B rebatable drugs under the Medicare prescription drug inflation rebate program, see this CMS fact sheet.
HHS also has launched LowerDrugCosts.gov, a new website for Medicare beneficiaries with information related to the drug pricing provisions under the Inflation Reduction Act as well as resources for Medicare enrollees and other interested parties.
Related Content
![Joey Solitro](png/clg6elv5hiwxvnm8dtmboc.png)
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Strategies to Optimize Your Social Security Benefits
To maximize what you can collect, it’s crucial to know when you can file, how delaying filing affects your checks and the income limit if you’re still working.
By Jason “JB” Beckett Published
-
Don’t Forget to Update Beneficiaries After a Gray Divorce
Some states automatically revoke a former spouse as a beneficiary on some accounts. Waivers can be used, too. Best not to leave it up to your state, though.
By Andrew Hatherley, CDFA®, CRPC® Published
-
Starbucks BOGO and New Sweet and Spicy Drinks
For a limited time, Starbucks is announcing four new "swicy" drinks that are both spicy and sweet.
By Kathryn Pomroy Published
-
Walmart Lawsuit: Get Up to $500 as Part of a $45 Million Settlement
You could be eligible to receive up to $500 as a result of Walmart's class-action lawsuit settlement.
By Erin Bendig Published
-
Credit Card Bonuses up to $1,600 for New Cardholders
Earn up to $1,600 when you sign up for a new credit card. Here are the best welcome offers for new cardholders.
By Ellen Kennedy Published
-
March CPI Report Comes in Hot: What the Experts Are Saying About Inflation
CPI A blowout inflation report pushes back the timing of Fed rate cuts.
By Dan Burrows Published
-
How To Invest Your Tax Return
When thinking about how to invest your tax return, prioritize your financial health over aggressive – and risky – ideas like bitcoin.
By Jeff Reeves Published
-
Solar Eclipse Snacks: 25 Best Deals for Enjoying the Big Day
Watch the solar eclipse while feasting on these great deals from Burger King, MoonPie, Applebee's, Krispy Kreme and more.
By Kathryn Pomroy Last updated
-
Solar Eclipse Glasses: Where to Buy, Where to Get Them Free
Find safe solar eclipse glasses at Warby Parker, Target, Amazon and more than 13,000 libraries nationwide
By Kathryn Pomroy Last updated
-
March Jobs Growth Blows Past Estimates: What the Experts Are Saying
Jobs Report A whopper of a jobs report could complicate the Fed's rate-cut plans.
By Dan Burrows Published